XIANGXUE PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.61 CNY | -0.28% |
|
+3.74% | -29.90% |
| Sales 2021 | 2.97B 410M | Sales 2022 | 2.19B 302M | Capitalization | 3.96B 547M |
|---|---|---|---|---|---|
| Net income 2021 | -688M -94.95M | Net income 2022 | -533M -73.56M | EV / Sales 2021 | 2.81 x |
| Net Debt 2021 | 3.08B 425M | Net Debt 2022 | 2.29B 316M | EV / Sales 2022 | 2.86 x |
| P/E ratio 2021 |
-7.76
x | P/E ratio 2022 |
-7.49
x | Employees | 2,417 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 37.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.28% | ||
| 1 week | +3.74% | ||
| Current month | -18.14% | ||
| 1 month | -13.43% | ||
| 3 months | -22.70% | ||
| 6 months | -29.08% | ||
| Current year | -29.90% |
1 week
3.38
3.66
1 month
3.324.74
Current year
3.005.35
1 year
3.006.45
3 years
3.009.79
5 years
3.0014.48
10 years
3.0051.41
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Hui Wang
CEO | Chief Executive Officer | 62 | 97-12-15 |
Wei Hua Huang
CHM | Chairman | 53 | 05-10-31 |
Zhi Ying Kang
CTO | Chief Tech/Sci/R&D Officer | 47 | 19-06-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yong Hui Wang
CEO | Chief Executive Officer | 62 | 97-12-15 |
Jun Hui Chen
BRD | Director/Board Member | 57 | 12-03-27 |
Wen Jin Chen
BRD | Director/Board Member | 51 | 22-06-23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 3.61 | -0.28% | 8 034 628 |
| 24-04-25 | 3.62 | +1.12% | 8,187,633 |
| 24-04-24 | 3.58 | +0.85% | 6,657,803 |
| 24-04-23 | 3.55 | +2.60% | 8,980,501 |
| 24-04-22 | 3.46 | +0.87% | 6,710,047 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
XIANGXUE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the research, development, production and distribution of traditional Chinese medicines and herbal decoction pieces. The Company's main products include antiviral oral liquids, indigowoad root granules, Exocarpium Citri Reticulatae series Chinese patent drugs and herbal decoction pieces, among others. The Company is also involved in the manufacture and sale of medical devices, health products, soft drinks and biological products. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -29.90% | 330M | |
| -15.13% | 4.49B | |
| -9.75% | 3.06B | |
| +2.14% | 3.04B | |
| -6.82% | 2.61B | |
| +47.87% | 1.81B | |
| +0.09% | 1.66B | |
| -7.89% | 1.63B | |
| -12.97% | 1.55B | |
| +33.40% | 1.41B |
- Stock Market
- Equities
- 300147 Stock
